Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Mark Erlander Net Worth & Insider Trades

Mark Erlander - Chief Executive Officer, Cardiff Oncology, Inc

As of March 16, 2023

What is Mark Erlander's Net Worth?

The current estimated net worth of Cardiff Oncology, Inc's Chief Executive Officer, Mark Erlander, is estimated to be about $0 . Mark Erlander owns about 24,481 units of Cardiff Oncology, Inc common stock. In the last 3 years at Cardiff Oncology, Inc, Mark Erlander has sold an estimated value of $0 worth.

What is Mark Erlander's Past Insider Trading?

Mark Erlander's largest purchase order was 10,000 units , worth over $14.3K on November 29, 2022. In total, Mark Erlander has made about 8 transactions over 3 years of their time at Cardiff Oncology, Inc. Mark Erlander usually trades in March, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mark Erlander

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark Erlander's' Mailing Address?

  • Mailing address is C/o Trovagene, Inc. 11055 Flintkote Avenue, Suite A San Diego CA 92121 CA

What are Cardiff Oncology, Inc's Past Insider Trades?

Cardiff Oncology, Inc's most recent insider trade came on November 14, 2023 by Gary Pace who bought 22,950 units worth $22.49K . In the last 3 years, insiders at Cardiff Oncology, Inc have sold an estimated value of $657.02K and bought an estimated value of $2.08M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Gary Pace, Director,  Mark Erlander, Chief Executive Officer,  and James Armitage, Director .

Cardiff Oncology, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...